FDA — authorised 8 April 2019
- Application: NDA211994
- Marketing authorisation holder: VIIV HLTHCARE
- Local brand name: DOVATO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 DOVATO in United States
FDA authorised DOVATO on 8 April 2019
Marketing authorisations
FDA
- Status: approved
DOVATO in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is DOVATO approved in United States?
Yes. FDA authorised it on 8 April 2019; FDA has authorised it.
Who is the marketing authorisation holder for DOVATO in United States?
VIIV HLTHCARE holds the US marketing authorisation.